News
This category can have multiple row spans for headers of first column.) Table borders are chosen randomly. We define border_categories with 4 possibilities (all four categories are equally likely to ...
ASCO GU 2024, CheckMate 214 trial, nivolumab, ipilimumab, nivolumab plus ipilimumab, renal cell carcinoma (RCC), checkpoint inhibitor combination therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results